Authors: Anscher, MS Marks, LB Shafman, TD Clough, R Huang, H Tisch, A Munley, M Herndon, JE Garst, J Crawford, J Jirtle, RL

Citation: Ms. Anscher et al., Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation, J CL ONCOL, 19(17), 2001, pp. 3758-3765

Authors: Johnston, E Crawford, J Blackwell, S Bjurstrom, T Lockbaum, P Roskos, L Yang, BB Gardner, S Miller-Messana, MA Shoemaker, D Garst, J Schwab, G

Citation: E. Johnston et al., Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy, J CL ONCOL, 18(13), 2000, pp. 2522-2528

Authors: DeVore, RF Johnson, DH Crawford, J Garst, J Dimery, IW Eckardt, J Eckhardt, SG Elfring, GL Schaaf, LJ Hanover, CK Miller, LL

Citation: Rf. Devore et al., Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer, J CL ONCOL, 17(9), 1999, pp. 2710-2720